AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3%
Thu, 21 May

AJANTA PHARMA has announced its results for the quarter ended March 2020. Here is a detailed performance review of the same:

AJANTA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-19*
3
Dec-19*
3
Mar-20*
QoQ ChangeYoY Change
Net SalesRs m5,1526,5126,8204.7%32.4%
Other incomeRs m16146567287.2%3377.9%
TurnoverRs m5,1686,6597,38710.9%42.9%
ExpensesRs m3,8814,6525,30614.1%36.7%
Gross profitRs m1,2711,8561,488-19.8%17.1%
DepreciationRs m18823626010.3%38.9%
InterestRs m81636130.6%370.1%
Profit before taxRs m1,0921,7511,7590.4%61.1%
TaxRs m203676467-30.9%130.0%
Profit after taxRs m8891,0761,29220.1%45.3%
Gross profit margin%24.728.521.8
Effective tax rate%18.638.626.6
Net profit margin%17.216.217.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 32.4% on a year-on-year (YoY) basis. The expenses were up by 36.7% YoY during the same period.
  • The company's operating profit increased by 17.1% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 21.8% in 4QFY20 as against 24.7% in 4QFY19.
  • Depreciation charges increased by 38.9% and finance costs increased by 370.1% YoY, respectively.
  • Other income increased by 3377.9% YoY during the quarter.
  • Net profit for the quarter increased by 45.3% YoY. Net profit margins during the quarter increased from 17.2% in 4QFY19 to 17.5% in 4QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 4.7% on a quarter-on-quarter (QoQ) basis. The expenses were up by 14.1% QoQ during the same period.
  • The company's operating profit declined by 19.8% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 21.8% in 4QFY20 as against 28.5% in 3QFY19.
  • Net profit for the quarter increased by 20.1% QoQ, while net profit margins increased from 16.2% in 3QFY19 to 17.5% in 4QFY20.

To see how AJANTA PHARMA has performed over the last eight quarters,please visit here.

The Instant Income Summit: Free Registration

AJANTA PHARMA Share Price Performance

Over the last one year,AJANTA PHARMA share price has moved up from Rs 1,014.7 to Rs 1,483.1, registering a Gain of Rs 468.4 or around 46.2%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 15,446.5 (up 0.6%). Over the last one year it has moved up from 13,260.3 to 15,446.5, a gain of 2,186 points (up 16.5%).

Overall, the S&P BSE SENSEX is down 21.1% over the year.

Current Valuations

At the current price of Rs 1,483.1, the price to earnings (P/E) ratio of AJANTA PHARMA stands at 27.9 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 5.8 times.

Equitymaster requests your view! Post a comment on "AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3%". Click here!

  

Related Views on News

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY20); Net Profit Down 7.2% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 7.2% YoY). Sales on the other hand came in at Rs 6 bn (up 18.1% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jul 7, 2020 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 8-QTR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS